Protagonist Therapeutics, Inc. (PTGX) is listed on NASDAQ in Pharmaceutical Stocks. It is $144.22, -3.53%, with a $9.3B market cap. RSI is 47.1, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 47.1 Neutral
Market Cap $9.3B
Volume 472.9K
Fundamentals — 10-Q Q2 2026
Revenue $269.8M
Net Income $166.6M
EPS $2.35
Operating Margin 57.5%
Net Margin 61.8%
P/E Ratio 61.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Patel Dinesh V Ph D | President and CEO | Sell | 100,000 | $148.91 | $14.9M | 2026 Aug 11 |
| Waddill William D. | Director | Sell | 9,000 | $117.94 | $1.1M | 2026 Jun 23 |
| Waddill William D. | Director | Sell | 9,000 | $107.68 | $969,120 | 2026 Jun 10 |
| Waddill William D. | Director | Sell | 9,000 | $99.64 | $896,760 | 2026 May 29 |
| Patel Dinesh V Ph D | President and CEO | Sell | 75,000 | $100.12 | $7.5M | 2026 May 12 |
| Patel Dinesh V Ph D | President and CEO | Sell | 75,000 | $100.12 | $7.5M | 2026 May 12 |
| Giraudo Bryan | Director | Sell | 59,130 | $100.10 | $5.9M | 2026 May 8 |
| Ali Asif | Chief Financial Officer | Sell | 1,750 | $105.47 | $184,573 | 2026 Apr 20 |
| Molina Arturo Md | Chief Medical Officer | Sell | 15,000 | $104.79 | $1.6M | 2026 Mar 26 |
| Selick Harold E | Director | Sell | 24,000 | $105.00 | $2.5M | 2026 Mar 26 |
| Ali Asif | Chief Financial Officer | Sell | 24,765 | $104.24 | $2.6M | 2026 Mar 26 |
| Patel Dinesh V Ph D | President and CEO | Sell | 54,700 | $101.00 | $5.5M | 2026 Mar 25 |
| Molina Arturo Md | Chief Medical Officer | Sell | 2,712 | $84.77 | $229,896 | 2025 Nov 17 |
| Waddill William D. | Director | Sell | 12,000 | $81.62 | $979,480 | 2025 Oct 10 |
| Waddill William D. | Director | Sell | 4,000 | $64.25 | $257,000 | 2025 Sep 22 |
| Waddill William D. | Director | Sell | 4,000 | $59.25 | $237,000 | 2025 Aug 27 |
| Patel Dinesh V Ph D | President and CEO | Sell | 10,415 | $54.78 | $570,534 | 2025 Jul 25 |
| Patel Dinesh V Ph D | President and CEO | Sell | 52,444 | $54.92 | $2.9M | 2025 Jul 23 |
| Molina Arturo Md | Chief Medical Officer | Sell | 20,000 | $56.27 | $1.1M | 2025 Jun 10 |
| Ali Asif | Chief Financial Officer | Sell | 1,756 | $46.00 | $80,776 | 2025 Apr 22 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $91.15 | 37.5 | $6.0B |
| | $70.09 | 38.5 | $5.8B |
| | $34.67 | 38.7 | $6.0B |
Take PTGX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put PTGX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Protagonist Therapeutics, Inc. next reports.
Set alerts on PTGX
Get notified when Protagonist Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free